Skip to content
Dose Brief
Menu
No. 17 here · Grade B+

No BS RX review

The only program tracked here that commits in writing to not using an intro rate — and the arithmetic on its own page backs the promise.

Visit No BS RX Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the score.
Semaglutide
$179/mo month-to-month (compounded)
Tirzepatide
$249/mo month-to-month (compounded)
Coverage
Not published
Brand-name
Compounded only

Prices read from No BS RX's own site on . Providers change pricing without notice — check the current figure before you buy.

On the trackerNewnew to the tracker, no prior reading— New to the tracker on 13 September 2026, read live off the provider's own pages that day rather than taken on trust. There is no earlier reading here to compare against, so the direction is "new" rather than stable — a first observation is not a trend. This is the one row where the thing to track is whether a promise holds: the page commits to no intro rate, and today the arithmetic agrees with it. A later reading either confirms that or is the story.

The scorecard

No BS RX scored on our six Brief Score factors. See the methodology.

Price Stability95/100
Supply Reliability92/100
Transparency92/100
Access Breadth88/100
Clinical Oversight74/100
Track Record70/100

What we like

  • "No Fake Intro Rate — the price on the page is the ongoing program price" is a named commitment, and the $140 in its hero really is a month-to-month rate on a real product
  • Names four dispensing pharmacies with street addresses and telephone numbers — Red Rock Compounding Pharmacy, Health Warehouse, Precision Medicine and Triad Rx
  • Every program row prints "503A pharmacy fulfillment" and "No dose-based price changes" on the table itself
  • Six programs across four terms published with no intake and no account, plus a separately priced sleep program

The caveats

  • The same $409 twelve-week block appears under three different monthly rates — an $11 saving against one and a $128 saving against another, styled identically
  • The low-dose programs stop at twelve weeks; only the standard programs carry 24- and 52-week rungs
  • The Terms name four pharmacies and no operating company
  • State availability is not published, and there is no brand-name lane

The brief

Best for: A reader who wants every term and every dose level comparable without starting an intake to see a price. The only program tracked here that commits in writing to not using an intro rate — and the arithmetic on its own page backs the promise.

Ranked #17 of 546 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Before you decide

The questions readers ask next after reading about No BS RX.

Closest here

The providers scoring nearest No BS RX — the realistic shortlist if you're weighing it.

Weighing No BS RX against one provider in particular? There is a full head-to-head with our top-ranked pick in CoreAge Rx vs No BS RX, and every provider that outranks it is listed on the No BS RX alternatives ranking.

More providers we track (24)

515 more are filed too — see every provider we track, ranked.

Pricing, states and verification reflect No BS RX's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on No BS RX's site. Not medical advice; see our disclosure.

← Back to all rankings